As the #1 prescribed cholesterol-lowering medication in the world, over 29 million people in the United States have been prescribed LIPITOR.1
LIPITOR has been studied in more than 400 ongoing and completed studies. These studies include over 80,000 patients.2
Three times more cardiologists surveyed would recommend LIPITOR to their own family members over other cholesterol-lowering medications‡
*Risk factors include family history, high blood pressure, age, low HDL ("good"
cholesterol), or smoking.
†Other risk factors include eye problem, kidney problem, smoking, or high
blood pressure.
‡Based on a response from 57 cardiologists in a Harris Interactive Survey
of 489 physicians, sampled from the American Medical Association master file, conducted
from April 2007-June 2007.
References:
Next: Staying on LIPITOR >>